{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:18:38Z","timestamp":1780525118976,"version":"3.54.1"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejphar.2021.173977","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T02:32:56Z","timestamp":1614220376000},"page":"173977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Brief review on repurposed drugs and vaccines for possible treatment of COVID-19"],"prefix":"10.1016","volume":"898","author":[{"given":"Priyasha","family":"De","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishita","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1908-1851","authenticated-orcid":false,"given":"Bhargavi","family":"Karna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8068-6484","authenticated-orcid":false,"given":"Nirmal","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.173977_bib1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2020.04.020","article-title":"Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza","volume":"181","author":"Abbott","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2021.173977_bib2","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1128\/JVI.00998-13","article-title":"Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms","volume":"87","author":"Adedeji","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2021.173977_bib3","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/AAC.02994-14","article-title":"Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses","volume":"58","author":"Adedeji","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2021.173977_bib4","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2021.173977_bib5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2021.173977_bib6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijid.2020.06.099","article-title":"Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19","volume":"97","author":"Arshad","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejphar.2021.173977_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.dsx.2020.04.020","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response","volume":"14","author":"Astuti","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.ejphar.2021.173977_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds","volume":"115","author":"B\u00e1ez-Santos","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2021.173977_bib9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.physiol.010908.163257","article-title":"Role of HDAC2 in the pathophysiology of COPD","volume":"71","author":"Barnes","year":"2009","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejphar.2021.173977_bib10","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19\u2014preliminary report","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.173977_bib11","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.1128\/JVI.00415-08","article-title":"Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide","volume":"82","author":"Bosch","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2021.173977_bib12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/s41587-020-0513-4","article-title":"CRISPR\u2013Cas12-based detection of SARS-CoV-2","volume":"38","author":"Broughton","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejphar.2021.173977_bib13","doi-asserted-by":"crossref","first-page":"e2134","DOI":"10.1002\/rmv.2134","article-title":"Covid-19: time for a paradigm change","volume":"30","author":"Buonaguro","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ejphar.2021.173977_bib14","series-title":"Experimental Treatment with Favipiravir for COVID-19: an Open-Label Control Study","volume":"vol. 2020","author":"Cai","year":"2020"},{"key":"10.1016\/j.ejphar.2021.173977_bib15","first-page":"3","article-title":"2020. Towards effective COVID-19 vaccines: updates, perspectives and challenges Int J","volume":"46","author":"Calina","year":"2020","journal-title":"Mol. Med."},{"key":"10.1016\/j.ejphar.2021.173977_bib16","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.173977_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy. immunopathology and its implications for therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2021.173977_bib18","doi-asserted-by":"crossref","first-page":"e10222","DOI":"10.7554\/eLife.10222","article-title":"Ternatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complex","volume":"4","author":"Carelli","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.ejphar.2021.173977_bib19","article-title":"Features, evaluation and treatment coronavirus (COVID-19)","author":"Cascella","year":"2020","journal-title":"Statpearls"},{"key":"10.1016\/j.ejphar.2021.173977_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1152\/physrev.00032.2014","article-title":"The physiology of protein S-acylation","volume":"95","author":"Chamberlain","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2021.173977_bib21","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1021\/acsnano.0c04006","article-title":"Nanotechnology for COVID-19: therapeutics and vaccine research","volume":"14","author":"Chauhan","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejphar.2021.173977_bib22","author":"Chen"},{"issue":"7","key":"10.1016\/j.ejphar.2021.173977_bib137","doi-asserted-by":"crossref","first-page":"ofaa241","DOI":"10.1093\/ofid\/ofaa241","article-title":"Antiviral activity and safety of darunavir\/cobicistat for the treatment of COVID-19","volume":"7","author":"Chen","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.ejphar.2021.173977_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2021.173977_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(03)13973-6","article-title":"Treatment of SARS with human interferons","volume":"362","author":"Cinatl","year":"2003","journal-title":"Lancet"},{"issue":"105932","key":"10.1016\/j.ejphar.2021.173977_bib25","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","volume":"55","author":"Colson","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejphar.2021.173977_bib26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.173977_bib27","series-title":"Coronavirus Vaccine Tracker","year":"2020"},{"key":"10.1016\/j.ejphar.2021.173977_bib28","first-page":"19","article-title":"COVID-19 therapies and vaccine landscape","volume":"809","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ejphar.2021.173977_bib29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/d41586-020-02154-2","article-title":"COVID-19 vaccines GET biotech boost","author":"Dance","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.173977_bib30","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture","volume":"58","author":"De Wilde","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2021.173977_bib32","series-title":"Draft Landscape of COVID-19 Candidate Vaccines","year":"2020"},{"key":"10.1016\/j.ejphar.2021.173977_bib31","series-title":"Public Health Image Library, Centers for Disease Control and Prevention, 2020","year":"2020"},{"key":"10.1016\/j.ejphar.2021.173977_bib33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41586-020-1930-8","article-title":"Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer","volume":"578","author":"Faivre","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.173977_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep01686","article-title":"Inhibition of novel \u03b2 coronavirus replication by a combination of interferon-\u03b12b and ribavirin","volume":"3","author":"Falzarano","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.173977_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molcel.2004.11.023","article-title":"VSV disrupts the Rae1\/mrnp41 mRNA nuclear export pathway","volume":"17","author":"Faria","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2021.173977_bib36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2021.173977_bib37","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1021\/jm9800144","article-title":"5-(5, 6-Dichloro-2-indolyl)-2-methoxy-2, 4-pentadienamides: novel and selective inhibitors of the vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity","volume":"41","author":"Gagliardi","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2021.173977_bib38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5582\/bst.2020.03072","article-title":"Update on use of chloroquine\/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Gao","year":"2020","journal-title":"BioSci. Trends"},{"key":"10.1016\/j.ejphar.2021.173977_bib39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"BioSci. Trends"},{"key":"10.1016\/j.ejphar.2021.173977_bib40","doi-asserted-by":"crossref","first-page":"7704","DOI":"10.1021\/acsnano.0c04596","article-title":"Back to normal: an old physics route to reduce SARS-CoV-2 transmission in indoor spaces","volume":"14","author":"Garcia de Abajo","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejphar.2021.173977_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/cpt.1856","article-title":"Optimizing hydroxychloroquine dosing for patients with COVID-19: an integrative modeling approach for effective drug repurposing","volume":"108","author":"Garcia-Cremades","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"issue":"105949","key":"10.1016\/j.ejphar.2021.173977_bib42","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejphar.2021.173977_bib43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S2666-5247(20)30121-X","article-title":"Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study","volume":"1","author":"Gibani","year":"2020","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ejphar.2021.173977_bib44","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1183\/09031936.00095809","article-title":"Azithromycin induces anti-viral responses in bronchial epithelial cells","volume":"36","author":"Gielen","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2021.173977_bib45","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/S0140-6736(20)31188-0","article-title":"Electron microscopy of SARS-CoV-2: a challenging task","volume":"395","author":"Goldsmith","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2021.173977_bib46","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.173977_bib47","article-title":"A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing","volume":"19","author":"Gordon","year":"2020","journal-title":"bioRxiv Prepr. Serv. Biol."},{"issue":"164","key":"10.1016\/j.ejphar.2021.173977_bib48","article-title":"Antimalarials\u2013are they effective and safe in rheumatic diseases?","volume":"56","author":"Ha\u0142adyj","year":"2018","journal-title":"Reumatologia"},{"key":"10.1016\/j.ejphar.2021.173977_bib49","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/ptr.6733","article-title":"Artemisia annua: trials are needed for COVID-19","volume":"34","author":"Haq","year":"2020","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2021.173977_bib50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0922-4106(94)90115-5","article-title":"Rat liver and kidney contain high densities of \u03c31 and \u03c32 receptors: characterization by ligand binding and photoaffinity labelling","volume":"268","author":"Hellewell","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.173977_bib51","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41586-020-2575-3","article-title":"Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2","volume":"585","author":"Hoffmann","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.173977_bib52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41565-020-0674-9","article-title":"Insights from nanomedicine into chloroquine efficacy against COVID-19","volume":"15","author":"Hu","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejphar.2021.173977_bib53","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/jmcb\/mjaa014","article-title":"Treating COVID-19 with chloroquine","volume":"12","author":"Huang","year":"2020","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2021.173977_bib54","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1161\/01.HYP.0000146120.29648.36","article-title":"Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor","volume":"44","author":"Huentelman","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2021.173977_bib55","author":"Ivanov"},{"key":"10.1016\/j.ejphar.2021.173977_bib56","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1073\/pnas.1617020114","article-title":"Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol","volume":"114","author":"Kadam","year":"2017","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"117627","key":"10.1016\/j.ejphar.2021.173977_bib57","article-title":"Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease","volume":"251","author":"Kandeel","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2021.173977_bib58","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jemt.23551","article-title":"Elucidating the microscopic and computational techniques to study the structure and pathology of SARS-CoVs","volume":"83","author":"Kaniyala Melanthota","year":"2020","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.ejphar.2021.173977_bib59","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12576-012-0195-x","article-title":"Voltage-dependent biphasic effects of chloroquine on delayed rectifier K+-channel currents in murine thymocytes","volume":"62","author":"Kazama","year":"2012","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.ejphar.2021.173977_bib60","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors","volume":"409","author":"Khan","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2021.173977_bib61","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1540-8159.2005.50146.x","article-title":"Polymorphic ventricular tachycardia with a normal QT interval following azithromycin","volume":"28","author":"Kim","year":"2005","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ejphar.2021.173977_bib62","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/AAC.03659-14","article-title":"Antiviral potential of ERK\/MAPK and PI3K\/AKT\/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis","volume":"59","author":"Kindrachuk","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2021.173977_bib63","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1371\/journal.pbio.0060226","article-title":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum","volume":"6","author":"Knoops","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejphar.2021.173977_bib64","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bbrc.2012.05.028","article-title":"TRIM59 interacts with ECSIT and negatively regulates NF-\u03baB and IRF-3\/7-mediated signal pathways","volume":"422","author":"Kondo","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2021.173977_bib65","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/j.bmcl.2017.04.056","article-title":"Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor","volume":"27","author":"Konno","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2021.173977_bib66","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","article-title":"The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2","volume":"22","author":"Kr\u00e4mer","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2021.173977_bib67","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1021\/acsmedchemlett.0c00254","article-title":"Exploiting existing molecular scaffolds for long-term COVID treatment","volume":"11","author":"Kumar","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2021.173977_bib68","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jac\/dkt310","article-title":"Treatment of classic Whipple's disease: from in vitro results to clinical outcome","volume":"69","author":"Lagier","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejphar.2021.173977_bib69","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41565-020-0752-z","article-title":"Dexamethasone.nanomedicines for COVID-19","volume":"15","author":"Lammers","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejphar.2021.173977_bib70","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.immuni.2011.06.014","article-title":"Mapping a dynamic innate immunity protein interaction network regulating type I interferon production","volume":"35","author":"Li","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2021.173977_bib71","author":"Li"},{"key":"10.1016\/j.ejphar.2021.173977_bib72","article-title":"Case of the index patient who caused tertiary transmission of COVID-19 infection in korea: the application of lopinavir\/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR","volume":"35","author":"Lim","year":"2020","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.ejphar.2021.173977_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-019-0132-8","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.ejphar.2021.173977_bib74","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1001\/jama.290.24.3222","article-title":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study","volume":"290","author":"Loutfy","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejphar.2021.173977_bib76","first-page":"370","article-title":"Perioperative glycemic management in 2011: paradigm shifts","volume":"17","author":"Maerz","year":"2011","journal-title":"Curr. Opin. Crit. Care"},{"key":"10.1016\/j.ejphar.2021.173977_bib77","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41586-020-2558-4","article-title":"Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates","volume":"585","author":"Maisonnasse","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.173977_bib78","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41594-020-0483-8","article-title":"Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation","volume":"27","author":"McCallum","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"104859","key":"10.1016\/j.ejphar.2021.173977_bib79","article-title":"Candidate drugs against SARS-CoV-2 and COVID-19","volume":"157","author":"McKee","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2021.173977_bib80","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01411-05","article-title":"Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones","volume":"50","author":"McKee","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2021.173977_bib82","series-title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV)","year":"2020"},{"key":"10.1016\/j.ejphar.2021.173977_bib81","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2021.173977_bib83","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virol.2013.11.040","article-title":"MERS-CoV papain-like protease has deISGylating and deubiquitinating activities","volume":"450","author":"Mielech","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.ejphar.2021.173977_bib84","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.devcel.2015.03.002","article-title":"CALM regulates clathrin-coated vesicle size and maturation by directly sensing and driving membrane curvature","volume":"33","author":"Miller","year":"2015","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ejphar.2021.173977_bib85","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1128\/JVI.03398-14","article-title":"Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step","volume":"89","author":"Mingo","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2021.173977_bib86","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bbrc.2011.10.113","article-title":"Sigma-1Rs are upregulated via PERK\/eIF2\u03b1\/ATF4 pathway and execute protective function in ER stress","volume":"415","author":"Mitsuda","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2021.173977_bib87","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/RHU.0b013e31829d5e50","article-title":"Suspected hydroxychloroquine-associated QT-interval prolongation in a patient with systemic lupus erythematosus","volume":"19","author":"Morgan","year":"2013","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.ejphar.2021.173977_bib88","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJMp1302726","article-title":"Cardiovascular risks with azithromycin and other antibacterial drugs","volume":"368","author":"Mosholder","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.173977_bib89","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.antiviral.2017.12.010","article-title":"Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona-and picornaviruses","volume":"150","author":"M\u00fcller","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2021.173977_bib90","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/art.10307","article-title":"Hydroxychloroquine concentration\u2013response relationships in patients with rheumatoid arthritis","volume":"46","author":"Munster","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2021.173977_bib91","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2021.173977_bib92","first-page":"e2163","article-title":"Azithromycin in viral infections","author":"Oliver","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ejphar.2021.173977_bib93","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/14756366.2016.1265519","article-title":"Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors","volume":"32","author":"Park","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejphar.2021.173977_bib94","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1021\/jm101251q","article-title":"Discovery and SAR of 5-(3-chlorophenylamino) benzo [c][2, 6] naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer","volume":"54","author":"Pierre","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2021.173977_bib95","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.drudis.2020.01.015","article-title":"Recent discovery and development of inhibitors targeting coronaviruses","volume":"25","author":"Pillaiyar","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2021.173977_bib96","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1462-5822.2007.00951.x","article-title":"Mouse hepatitis coronavirus replication induces host translational shutoff and mRNA decay, with concomitant formation of stress granules and processing bodies","volume":"9","author":"Raaben","year":"2007","journal-title":"Cell Microbiol."},{"issue":"231","key":"10.1016\/j.ejphar.2021.173977_bib97","article-title":"SARS-CoV-2 and coronavirus disease 2019: what we know so far","volume":"9","author":"Rabi","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.ejphar.2021.173977_bib98","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00596-16","article-title":"Casein kinase 2 is linked to stress granule dynamics through phosphorylation of the stress granule nucleating protein G3BP1","volume":"37","author":"Reineke","year":"2017","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2021.173977_bib99","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.173977_bib100","doi-asserted-by":"crossref","first-page":"e906","DOI":"10.1161\/CIRCULATIONAHA.120.047521","article-title":"Considerations for drug interactions on QTc in exploratory COVID-19 treatment","volume":"141","author":"Roden","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2021.173977_bib101","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1073\/pnas.0708153105","article-title":"The molecular basis of chloroquine block of the inward rectifier Kir2. 1 channel","volume":"105","author":"Rodr\u00edguez-Menchaca","year":"2008","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejphar.2021.173977_bib102","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1038\/sj.emboj.7601743","article-title":"SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK","volume":"26","author":"Ryzhakov","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2021.173977_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17189-2","article-title":"Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing","volume":"11","author":"Sadegh","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2021.173977_bib104","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/aid.2018.0178","article-title":"Simplification of antiretroviral treatment from darunavir\/ritonavir monotherapy to darunavir\/cobicistat monotherapy: effectiveness and safety in routine clinical practice","volume":"35","author":"Santos","year":"2019","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.ejphar.2021.173977_bib105","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1128\/JVI.00023-19","article-title":"High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses","volume":"93","author":"Shen","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2021.173977_bib106","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejphar.2021.173977_bib107","doi-asserted-by":"crossref","first-page":"17195","DOI":"10.1073\/pnas.2006560117","article-title":"Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface","volume":"117","author":"Shigdel","year":"2020","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejphar.2021.173977_bib108","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.bmc.2014.12.028","article-title":"Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors","volume":"23","author":"Shimamoto","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"283","key":"10.1016\/j.ejphar.2021.173977_bib109","article-title":"Saracatinib inhibits middle east respiratory syndrome-coronavirus replication in vitro","volume":"10","author":"Shin","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.ejphar.2021.173977_bib110","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41565-020-0737-y","article-title":"COVID-19 vaccine development and a potential nanomaterial path forward","volume":"15","author":"Shin","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejphar.2021.173977_bib111","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0162-3109(00)00193-4","article-title":"The structure of inosine 5\u2032-monophosphate dehydrogenase and the design of novel inhibitors","volume":"47","author":"Sintchak","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ejphar.2021.173977_bib112","series-title":"\u201cSolidarity\u201d Clinical Trial for COVID-19 Treatments","year":"2020"},{"key":"10.1016\/j.ejphar.2021.173977_bib113","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature07884","article-title":"An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer","volume":"458","author":"Soucy","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.173977_bib114","series-title":"Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV)","author":"Statement on the second meeting of the International Health Regulations","year":"2005"},{"issue":"1708","key":"10.1016\/j.ejphar.2021.173977_bib115","article-title":"Cytokine storm in COVID-19: the current evidence and treatment strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2021.173977_bib116","doi-asserted-by":"crossref","first-page":"e15874","DOI":"10.1371\/journal.pone.0015874","article-title":"Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol","volume":"6","author":"Teissier","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2021.173977_bib117","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCOUTCOMES.113.000152","article-title":"Development and validation of a risk score to predict QT interval prolongation in hospitalized patients","volume":"6","author":"Tisdale","year":"2013","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.ejphar.2021.173977_bib118","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/excr.2002.5613","article-title":"Azithromycin, a lysosomotropic antibiotic, has distinct effects on fluid-phase and receptor-mediated endocytosis, but does not impair phagocytosis in J774 macrophages","volume":"281","author":"Tyteca","year":"2002","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejphar.2021.173977_bib119","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants","volume":"10","author":"ul Qamar","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.ejphar.2021.173977_bib120","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01846-19","article-title":"High-dose chloroquine for uncomplicated plasmodium falciparum malaria is well tolerated and causes similar QT interval prolongation as standard-dose chloroquine in children","volume":"64","author":"Ursing","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2021.173977_bib121","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41563-020-0746-0","article-title":"Next-generation vaccine platforms for COVID-19","volume":"19","author":"van Riel","year":"2020","journal-title":"Nat. Mater."},{"issue":"202","key":"10.1016\/j.ejphar.2021.173977_bib122","article-title":"In vitro diagnostic assays for COVID-19: recent advances and emerging trends","volume":"10","author":"Vashist","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejphar.2021.173977_bib123","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ejphar.2021.173977_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.ejphar.2021.173977_bib125","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.ejphar.2021.173977_bib126","series-title":"WHO Coronavirus Disease (COVID-19) Dashboard","year":"2020"},{"key":"10.1016\/j.ejphar.2021.173977_bib127","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.virol.2006.05.028","article-title":"Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication","volume":"353","author":"Wilson","year":"2006","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.ejphar.2021.173977_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-14221-2","article-title":"A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery","volume":"7","author":"Wolfram","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.173977_bib129","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41594-020-0468-7","article-title":"SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects","volume":"27","author":"Wrobel","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejphar.2021.173977_bib130","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2011.02.022","article-title":"NLRX1 negatively regulates TLR-induced NF-\u03baB signaling by targeting TRAF6 and IKK","volume":"34","author":"Xia","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2021.173977_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1448-9","article-title":"NOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2","volume":"38","author":"Xu","year":"2019","journal-title":"J. Exp. Clin. Canc. Res."},{"key":"10.1016\/j.ejphar.2021.173977_bib132","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1128\/JVI.78.11.5642-5650.2004","article-title":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN","volume":"78","author":"Yang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2021.173977_bib133","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12012-017-9401-7","article-title":"Electrophysiologic studies on the risks and potential mechanism underlying the proarrhythmic nature of azithromycin","volume":"17","author":"Zhang","year":"2017","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.ejphar.2021.173977_bib134","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/jac\/dkaa114","article-title":"COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression","volume":"75","author":"Zhou","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejphar.2021.173977_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17796-z","article-title":"Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells","volume":"11","author":"Zhu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2021.173977_bib136","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921001308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921001308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:46:36Z","timestamp":1757976396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921001308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":136,"alternative-id":["S0014299921001308"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173977","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brief review on repurposed drugs and vaccines for possible treatment of COVID-19","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173977","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173977"}}